Med24
Medical Research 16. 10. 2026 • 2 min read • medical-news

Drug-coated balloons offer an alternative to permanent heart stents

Thousands of heart patients could be treated without having a metal stent permanently implanted in their arteries - according to research from the University of East Anglia (UEA).

Drug-coated balloons offer an alternative to permanent heart stents

Research from the University of East Anglia (UEA) indicates that drug-coated balloons offer a viable alternative to permanently implanted metal stents for treating heart patients. A major analysis of over 7,800 patients revealed that this newer treatment performed similarly to conventional stents in preventing heart attacks and cardiovascular deaths.

Drug-coated balloons are removed after treatment, contrasting with the permanent nature of stents. The research, published in The Lancet's eClinicalMedicine, suggests this approach could provide a safe alternative for patients. Lead researcher Dr Natasha Corballis explained that drug-coated balloons release medicine into the artery wall as they are inflated, preventing re-narrowing. The study found no meaningful difference in the most serious outcomes between patients treated with drug-coated balloons and those receiving stents. Rates of heart attack were also virtually identical between the two groups.

The analysis included data from 10 randomized clinical trials. The findings remained consistent even when researchers excluded studies focusing on small coronary arteries, where drug-coated balloons already have established evidence. However, the research also identified a potential drawback: patients treated with drug-coated balloons were more likely to require a repeat procedure, known as revascularization, to reopen the artery, particularly when treating larger arteries. Researchers cautioned that the finding appeared heavily influenced by a single clinical trial and that there was considerable variation between studies.

Sponsored content

The research adds to growing interest in the ‘leave nothing behind’ strategy, aiming to restore blood flow without permanent devices. Senior author Prof Vassilios Vassiliou noted that this approach could reduce longer-term complications associated with stents while preserving future treatment options. Larger clinical trials with longer follow-up periods are needed to determine the effectiveness of drug-coated balloon treatment in larger vessels and more complicated coronary lesions.

Original Scientific Source
medical-news
View Original Source
Medical Disclaimer All calculations, recommendations, and interpretations provided by this tool are for informational and educational purposes only. They do not substitute professional medical advice, diagnosis, or treatment. Always consult your physician regarding any health concerns.

Recommended Medical News

All news →
Advertisement